Biochemical aspects of the pathogenesis of temporomandibular joint disorders

Asian Journal of Oral and Maxillofacial Surgery

Volumn 15, Issue 2, 2003, Pages 118-127

  Tomida, Mihoko ^a   Ishimaru, Jun Ichi ^b   Miyamoto, Ken ^a   Mizui, Takumi ^b   Esaki, Yuki ^a   Hayashi, Tomoya ^a   Murayama, Koichi ^a   Era, Seiich ^a   Shibata, Toshiyuki ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

Author keywords

Albumins; Antioxidants; Free radicals; Temporomandibular joint disorder

Indexed keywords

COLLAGEN; FREE RADICAL; HYALURONIC ACID; PROTEOGLYCAN;

COLLAGEN DEGRADATION; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; OXIDATIVE STRESS; REVIEW; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT DISORDER;

EID: 0038716766     PISSN: 09156992     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0915-6992(03)80020-1     Document Type: Article

References (83)

1. Carlsson GE, Egermark I, Magnusson T. Predictors of signs and symptoms of temporomandibular disorders: a 20-year follow-up study from childhood to adulthood. Acta Odontol Scand 2002;60:180-185.
2. Ishimaru JI, Handa Y, Kurita K, Goss AN. The effect of occlusal loss on normal and pathological temporomandibular joint: an animal study. J Cranio-Maxillofac Surg 1994;22:95-102.
3. Goss, AN, Bosanquet AG. The arthroscopic appearance of acute temporomandibular joint trauma. J Oral Maxillofac Surg 1990;48:780-783.
4. Kahn J Tallents RH, Katzberg RW, Ross ME, Murphy WC. Prevalence of dental occlusal variables and intraarticular temporomandibular disorders: molar relationship, lateral guidance, and nonworking side contacts. J Prosthet Dent 1999;82:410-415.
5. Haskin CL, Milam SB, Cameron IL. Pathogenesis of degenerative joint disease in the human temporomandibular joint. Crit Rev Oral Biol Med 1995;6:248-277.
6. Israel HA. Current concept in the surgical management of temporomandibular joint disorders. J Oral Maxillofac Surg 1994;52:289-294.
7. Ishimaru JI, Kurita K, Handa Y, Goss AN. Temporomandibular joint osteoarthritis literature review and experimental animal models. Hosp Dent (Tokyo) 1991;3:20-24.
8. Fu K, Ma X, Xhang Z, Chen W. Tumor necrosis factor in synovial fluid of patients with temporomandibular disorders. J Oral Maxillofac Surg 1995;53:424-426.
9. Shinmei M, Miyauchi S, Machida A, Miyazaki K. Quantitation of chondroitin 4-sulfate and chondroitin 6-sulfate in pathologic joint fluid. Arthritis Rheum 1992;35:1304-1308.
10. Okada Y, Nagase H, Harris ED. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. J Biol Chem 1986;261:14245-14255.
11. Halliwell B, Gutteridge JM, Blake D. Metal ions and oxygen radical reactions in human inflammatory joint disease. Phil Trans R Soc Lond B 1985;311:659-671.
12. 4 in synovial fluid of painful, dysfunctional temporomandibular joints. J Oral Maxillofac Surg 1990;48:968-971.
13. Kubota E, Kubota T, Matsumoto J, Shibata T, Murakami KI. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg 1998;56:192-198.
14. Shibata T, Murakami KI, Kubota E, Maeda H. Glycosaminoglycan components in temporomandibular joint synovial fluid as markers of joint pathology. J Oral Maxillofac Surg 1998;56:209-213.
15. Alstergren P, Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E. Co-variation of neuropeptide Y, calcitonin gene related peptide, substance P and neurokinin A in joint fluid from patients with temporomandibular joint arthritis. Arch Oral Biol 1995;40:127-135.
16. Ishimaru JI Oguma Y, Goss AN. Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and lavage synovial fluid of patients with temporomandibular joint disorders. Br J Maxillofac Surg 2000;38:354-359.
17. Milam SB, Zardeneta G, Schmitz JP. Oxidative stress and degenerative temporomandibular joint disease: a proposed hypothesis. J Oral Maxillofac Surg 1998;56:214-223.
18. Nitzan DW. The process of lubrication impairment and its involvement in temporomandibular joint disc displacement: a theoretical concept. J Oral Maxillofac Surg 2001;59:36-45.
19. Quinn JH, Kent JH, Moise A, Lukiw WJ. Cyclooxygenase-2 in synovial tissue and fluid of dysfunctional temporomandibular joints with internal derangement. J Oral Maxillofac Surg 2000;58:1229-1232.
20. Larsson J, Ekblom A, Henriksson K, Lundeberg T, Theodoesson E. Immunoreactive tachykinins, calcitonin gene-related peptide and neuropeptide Y in human synovial fluid from inflamed joint. Neurosci Lett 1989;100:326-330.
21. Larsson J, Ekblom A, Henriksson K, Lundeberg T, Theodoesson E. Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis. Scand J Rheumatol 1991;20:326-335.
22. Holt I, Cooper RG, Denton J, Meager A, Hopkins SJ. Cytokine inter-relationships and their association with disease activity in arthritis. Br J Rheumatol 1992;31:725-733.
23. Takahashi T, Kondoh T, Kamei K, Seki H, Fukuda M, Nagai H, Takano H, Yamazaki Y. Elevated levels of nitric oxide in synovial fluid from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:505-509.
24. Smith AJ, Basu MK, Speculand B, Kassem MA, Lloyd JM. Synovial fluid glycosaminoglycan (acid mucopolysaccharide) analysis in assessment of temporomandibular joint dysfunction: a pilot study. Br J Oral Maxillofac Surg 1989;27:853-861.
25. Israel HA, Saed-Nejad F, Ratcliffe A. Early diagnosis of osteoarthritis of the temporomandibular joint: correlation between arthroscopic diagnosis and keratan sulfate levels in synovial fluid. J Oral Maxillofac Surg 1991;49:708-711.
26. Kopp S, Wenneberg B, Clemensson E. Clinical, microscopical and biochemical investigation of synovial fluid from temporomandibular joints. Scand J Dent Res 1983;91:33-41.
27. Henderson B, Higgs GA. Synthesis of arachidonate oxidation products by synovial joint tissues during the development of chronic erosive arthritis. Arthritis Rheum 1987;30:1149-1156.
28. Alstergren P, Kopp S. Prostaglandin E2 in temporomandibular joint synovial fluid and its relation to pain and inflammatory disorders. J Oral Maxillofac Surg 2000;58:180-186.
29. Takahashi T, Nagai H, Seki H, Fukuda M. Relationship between joint effusion, joint pain, and protein levels in joint lavage fluid of patients with internal derangement and osteoarthritis of the temporomandibular joint. J Oral Maxillofac Surg 1999;57:1187-1193.
30. Kimball ES, Fisher MC. Potentiation of IL-1-induced BALB/3T3 fibroblast proliferation by neuropeptides. J Immunol 1988;141:4203-4208.
31. Ohlen A, Lindbom L, Staines W, Hokfelt T, Cuello AC, Fischer JA, Hedqvist P. Substance P and calcitonin gene-related peptide: immunohistochemical localisation and microvascular effects in rabbit skeletal muscle. Naunyn Schmiedebergs Arch Pharmacol 1987;336:87-93.
32. Nakamura-Craig M, Gill BK. Effect of neurokinin A, substance P and calcitonin gene related peptide in peripheral hyperalgesia in the rat paw. Neurosci Lett 1991;124:49-51.
33. Lundberg JM, Terenius L, Hokfelt T, Martling CR, Tatemoto K, Mutt V, Polak J, Bloom S, Goldstein M. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 1982;116:477-480.
34. Alstergren P, Kopp S, Theodorsson E. Synovial fluid sampling from the temporomandibular joint: sample quality criteria and levels of interleukin-1 beta and serotonin. Acta Odontol Scand 1999;57:16-22.
35. Yoshihara Y, Obata K, Fujimoto N, Yamashita K, Hayakawa T, Shimmei M. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 1995;38:969-975.
36. Tanaka A, Kumagai S, Kawashiri S, Takatsuka S, Nakagawa K, Yamamoto E, Matsumoto N. Expression of matrix metalloproteinase-2 and -9 in synovial fluid of the temporomandibular joint accompanied by anterior disc displacement. J Oral Pathol Med 2001;30:59-64.
37. 2, hyaluronic acid, and chondroitin-4 and -6 sulfates in temporomandibular joint synovial fluid of patients with internal derangement. J Oral Maxillofac Surg 1998;56:199-203.
38. Shibata T, Murakami KI, Kubota E, Maeda H. Glycosaminoglycan components in temporomandibular joint synovial fluid as markers of joint pathology. J Oral Maxillofac Surg 1998;56:209-213.
39. Ishimaru JI, Ogi N, Mizuno S, Goss AN. Quantitation of chondroitin-sulfates, disaccharides and hyaluronan in normal, early and advanced osteoarthritic sheep temporomandibular joints. Osteoarthritis Cartilage 2001;9:365-370.
40. Halliwell, B. Oxidants and human disease: some new concepts. FASEB J 1987;1:358-364.
41. Dizdaroglu M, Dirksen ML, Jiang HX, Robbins JH. Ionizing-radiation-induced damage in the DNA of cultured human cells. Biochem J 1987;241:929-932.
42. Davies KJ. Tracellular proteolytic systems may function as secondary antioxidant defenses: a hypothesis. J Free Radic Biol Med 1986;2:155-173.
43. Wolff SP, Dean RT. Fragmentation of proteins by free radicals and its effect on their susceptibility to enzymic hydrolysis. Biochem J 1986;234:399-403.
44. Gey KF, Brubacher GB, Stahelin HB. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr 1987;45:1368-1377.
45. Flohe L, Beckmann R, Giertz H, Loschien G. Oxygen-centered free radicals as mediators of inflammation. In: Sies H, editor. Oxidative stress. New York: Academic Press; 1985:403.
46. Cutler RG. Aging and oxygen radicals. In: Taylor AE, editor. Physiology of oxygen radicals. Am Physiol Soc Bethesda 1986:251.
47. Saari H. Oxygen derived free radicals and synovial fluid hyaluronate. Ann Rheum Dis 1991;50:389-392.
48. Gutteridge JM. Bleomycin-detectable iron in knee-joint synovial fluid from arthritic patients and its relationship to the extracellular antioxidant activities of ceruloplasmin, transferrin and lactoferrin. Biochem J 1987;245:415-421.
49. Zardeneta G, Milam SB, Schmitz JP. Presence of denatured hemoglobin deposits in diseased temporomandibular joints. J Oral Maxillofac Surg 1997;55:1242-1248.
50. Palmer RM, Ferrige AG, Moncada S. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
51. Michel T, Feron O. Nitric oxide synthases: which, where, how and why? J Clin Invest 1997;100:2146-2152.
52. Takahashi T, Kondoh T, Ohtani M, Homma H, Fukuda M. Association between arthroscopic diagnosis of temporomandibular joint osteoarthritis and synovial fluid nitric oxide levels. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:129-136.
53. Homma H, Takahashi T, Seki H, Ohtani M, Kondoh T, Fukuda M. Immunohistochemical localization of inducible nitric oxide synthase in synovial tissue of human temporomandibular joints with internal derangement. Arch Oral Biol 2001;46:93-97.
54. Murakami KI, Segami N, Fujimura K, Iizuka T. Correlation between pain and sunovitis in patients with internal derangement of the temporomandibular joint. J Oral Maxillofac Surg 1991;49:1159-1161.
55. Suenaga S, Abeyama K, Hamasaki A, Mimura T, Noikura T. Temporomandibular disorders: relationship between joint pain and effusion and nitric oxide concentration in the joint fluid. Dentomaxillofac Radiol 2001;30:214-218.
56. Amin AR, Abramson SB. The role of nitric oxide in articular cartilage breakdown in osteoarthritis. Curr Opin Rheumatol 1998;10:263-268.
57. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-163.
58. McCord JM. Free radical and inflammation: Protection of synovial fluid by superoxide dismutase. Science 1974;185:529-531.
59. Greenwald RA, Moy WW. Effect of oxygen-derived free radicals on hyaluronic acid. Arthritis Reum 1980;23:455-463.
60. Schalkwijk J, van den Berg WB, van de Putte LB, Joosten LA. Hydrogen peroxide suppresses the proteoglycan synthesis of intact articular cartilage, J Rheumatol 1985;12:205-210.
61. Bates EJ, Harper GS, Lowther DA, Preston BN. Effect of oxygen derived reactive species on cartilage proteoglycan-hyaluronate aggregates. Biochem Int 1984;8:629-637.
62. Myint P, Deeble DJ, Beaumont PC, Blake SM, Phillips GO. The reactivity of various free radicals with hyaluronic acid: steady state and pulse radiolysis studies. Biochim Biophys Acta 1987;925:194-202.
63. Roberts CR, Roughley PJ, Mort JS. Degradation of human proteoglycan aggregate induced by hydrogen peroxide: protein fragmentation, amino acid modification and hyaluronic acid cleavage. Biochem J 1989;259:805-811.
64. Monboisse JC, Gardes-Albert M, Randoux A, Borel JP, Ferradini C. Collagen degradation by superoxide anion in pulse and gamma radiolysis. Biochim Biophys Acta 1988;965:29-35.
65. Salin ML, McCord JM. Free radicals and inflammation. J Clin Invest 1975;56:1319-1323.
66. Machlin LJ, Bendich A. Free radical tissue damage: protective role of antioxidant nutrients. FASEB J 1987;1:441-445.
67. Halliwell B, Gutteridge JM. The antioxidants of human extracellular fluid. Arch Biochem Biophys 1990;280:1-8.
68. Halliwell B. Albumin - An important extracellular antioxidant? Biochem Pharmacol 1988;37:569-571.
69. Finch JW, Crouch RK, Knapp DR, Schey KL. Mass spectrometric identification of modifications to human serum albumin treated with hydrogen peroxide. Arch Biochem Biophys 1993;305:595-599.
70. Sogami M, Era S, Nagaoka S, Kuwata K, Kida K, Miura K, Inouye H, Suzuki E, Hayano S, Sawada S. HPLC-studies on nonmercapt-mercapt conversion of human serum albumin. Int J Peptide Protein Res 1985;25:398-402.
71. Era S, Hamaguchi T, Sogami M, Kuwata K, Suzuki E, Miura K, Kawai K, Kitazawa Y, Okabe H, Noma A, Miyata S. Further studies on the resolution of human mercapt- and nonmercaptalbumin and on human serum albumin in the elderly by high-performance liquid chromatography. Int J Peptide Protein Res 1988;31:435-442.
72. Era S, Kuwata K, Sogami M, Suzuki E, Miura K, Kawai K, Takahashi K, Hayano S, Iwama T, Okabe H, Noma A, Uji Y, Hamaguchi T, Miyata S. High-performance liquid chromatographic (HPLC) studies on structural alteration of human serum albumin in the elderly. Precision Machinery 1989;2:157-168.
73. Era S, Kuwata K, Imai H, Nakamura K, Hayashi T, Sogami M. Age-related change in redox state of human serum albumin. Biochim Biophys Acta 1995;1247:12-16.
74. Kacena MA, Merrel GA, Konda SR, Wilson KM, Xi Y, Horowitz MC. Inflammation and bony changes at the temporomandibular joint. Cells. Tissues Organs 2001;169:257-64.
75. Symons MC. Formation of radicals by mechanical processes. Free Rad Res Commun 1988;5:131-139.
76. Blake DR, Merry P, Unsworth J, Kidd BL, Outhwaite JM, Ballard R, Morris CJ, Gray L, Lunec J. Hypoxic-reperfusion injury in the inflamed human joint. Lancet 1989;11:289-293.
77. Hertz F, Cloarec A. Pharmacology of free radicals: recent views on their relation to inflammatory mechanisms. Life Sci 1984;34:713-720.
78. Mapp PI, Grootveld MC, Blake DR. Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull 1995;51:419-436.
79. Grootveld M, Henderson EB, Farrell A, Blake DR, Parkes HG, Haycock P. Oxidative damage to hyluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Biochem J 1991;273:459-467.
80. Burkhardt H, Schwingel M, Meninger H, Macartney HW, Tschesche H. Oxygen radicals a effectors of cartilage destruction. Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes. Arthritis Rheum 1986;29:379-387.
81. Henrotin Y, Deby-Dupont G, Deby C, Franchimont P, Emerit I. Active oxygen species, articular inflammation and cartilage damage. Exs 1992;62:308-322.
82. Kawai Y, Kubota E, Okabe E. Reactive oxygen species participation in experimentally induced arthritis of the temporomandibular joint in rats. J Dent Res 2000;79:1489-1495.
83. Hayashi T, Era S, Kawai K, Nakamura K, Onda E, Yoh M. Observation for redox state of human serum and aqueous humor albumin from patients with senile cataract. Pathophysyology 2000;6:237-243.